Tianyin Pharmaceutical Co., Inc. to Host First Quarter Fiscal 2010 Earnings Conference Call and Webcast on Friday, November 13th, 2009 at 10:30 a.m. ET
CHENGDU, China, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Tianyin
Pharmaceutical, Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of
modernized traditional Chinese medicine ('TCM') based in Chengdu, China, today
announced that management will hold a conference call to discuss its fiscal
2010 first quarter results at 10:30 a.m. ET on Friday, November 13, 2009.
Financial results will be released prior to the market open on that day. A
PowerPoint presentation which provides further details on the quarter and the
recently announced Sichuan Jiangchuan Pharmaceutical Co. Ltd. joint venture
will accompany management's discussion and can be accessed via the webcast
link.
Call Access Information:
(877) 941-2321 from within the United States
(480) 629-9714 if calling internationally
Conference ID is 4182573
A replay will be available through November 21, 2009 and can be accessed
by dialing (800) 406-7325 (U.S.), (303) 590-3030 (Int'l), Pin Code 4182573.
Tianyin is a manufacturer and supplier of modernized traditional Chinese
medicine in China. It was established in 1994 and acquired by the current
management team in August 2003. It has a comprehensive product portfolio of
39 products, 22 of which are listed in the highly selective National Medicine
Catalog of the National Medical Insurance program. Tianyin owns and operates
three GMP manufacturing facilities and an R&D platform supported by leading
Chinese academic institutions. The company has a pipeline of 17
pharmaceutical products pending approval. Tianyin has an extensive nationwide
distribution network throughout China with a sales force of 720 salespeople.
Tianyin is headquartered in Chengdu, Sichuan Province with three manufacturing
facilities and a total of 1,365 employees. For more information about Tianyin,
please visit http://www.tianyinpharma.com .
Safe Harbor Statement
The Statements which are not historical facts contained in this press
release are forward-looking statements that involve certain risks and
uncertainties including but not limited to risks associated with the
uncertainty of future financial results, additional financing requirements,
development of new products, government approval processes, the impact of
competitive products or pricing, technological changes, the effect of economic
conditions and other uncertainties detailed in the Company's filings with the
Securities and Exchange Commission.
